LONDON, UNITED KINGDOM  June 16, 2021 — Sciton® Inc., a leading manufacturer of medical and aesthetic lasers and light source technologies based in Palo Alto, California, announces the launch of its latest platform, mJOULE, in the United Kingdom. This revolutionary system features some of the biggest updates in the history of pulsed light-based technology, including its newest fractional treatment, MOXI, and the award-winning BBL HERO treatment.

“At Sciton, we work hand in hand with our clinician partners to drive visionary innovation that is founded on science and uncompromised quality,” shares Aaron Burton, Sciton CEO. “We are proud to be leading the industry with new product innovation and enhancements that benefit practices and patients alike.”

mJOULE is a dual-wavelength platform that features BBL HERO and MOXI technologies, created in response to a changing market that desires less time-consuming treatments, yet equally strong outcomes. Recently honored by NewBeauty as a 2020 ‘Innovation Award Winner,’ BBL HERO (High Energy Rapid Output) is the fastest, most powerful IPL in the industry, and empowers practitioners to treat the entire body with four times the speed, three times the peak intensity, allowing for a highly customizable protocol. The treatment results in smoother, clearer, younger, and healthier-looking skin in just one to two sessions.
“Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high-quality devices and marketing efforts for our physician and medspa partners worldwide.” says Lacee J. Naik, Vice President of Marketing and Public Relations.

The second technology available on the mJOULE platform is Sciton’s newest fractional laser, MOXI. MOXI is one of the most inclusive laser treatments available and is safely suitable for those higher on the Fitzpatrick scale. This non-ablative laser addresses sun damage and aging, takes under 20 minutes and boasts little to no downtime, allowing it to fit comfortably into even the busiest of schedules, and can be performed any time of the year.

“The U.K. is an important market for Sciton’s global growth strategy,” says David Percival, Vice-President and General Manager for Sciton International. “We see a tremendous opportunity to introduce both these novel technologies into the growing aesthetic market in the U.K. We have a strong reputation for delivering an outstanding customer experience and look forward to expanding our Sciton family of customers.”

Sciton will celebrate this monumental international launch with a premier event in London on June 24th, 2021, where staff, partners, and leadership will gather to recognize this milestone and officially welcome their ground-breaking technologies to the dynamic UK market.

ABOUT SCITON
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.

The post Sciton Celebrates the Newest Innovation In United Kingdom: Sciton’s mJOULE appeared first on Sciton.

Sciton will be showcasing its premier aesthetic technology in the heart of one of the most famous medical aesthetics areas in the world. “Harley Street in London represents an area well known for excellence in medical aesthetics. It is the perfect place to be able to share techniques for proven Sciton treatments like BBL HERO, Halo and MOXI.” said David Higham, U.K. Country Manager.

Sciton has partnered with Skin Group International Ltd (SGI) to support education in laser theory and application for medical providers looking to expand their skills.  SGI’s newest qualifications are for Level 2 – Level 7 Non-Surgical Skin Procedures and participants in these courses will be able to get hands-on time with Sciton’s premium laser and light technology. “This partnership will provide Sciton’s U.K. and E.U. customers with access to the highest standards of laser education and demonstrates our commitment to safety, support, and advanced training,” said Matthew Gelber, Director of Sciton – EMEA.

ABOUT SCITON
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.

The post Sciton U.K. Announces Central London Flagship Showroom and Training Centre in Partnership With Skin Group International Ltd (SGI) appeared first on Sciton.

Sciton will be expanding its marketing, sales, clinical education, and service offerings through direct operations. “The U.K. is an important market for Sciton’s global growth strategy, and we look forward to introducing our innovative aesthetic technologies with an outstanding customer experience to match,” said David Percival, Vice-President and General Manager for Sciton International. Sciton will leverage the insight and expertise of the U.K.’s internationally renowned aesthetic physicians to strengthen their market position. “We are confident that our focused efforts will greatly benefit our U.K. customers. We are also thrilled to introduce our JouleX platform with well-established treatments such as Halo and ClearV along with our new fractional treatment, MOXI, and BBL HERO, the biggest advancement in the history of pulsed light-based technology,” said Matthew Gelber, Director of Sciton – EMEA/LATAM.

ABOUT SCITON
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.

The post Sciton Announces the Launch Of Direct Operations In The United Kingdom appeared first on Sciton.